This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
Questions about our CME?
Questions about our CME?

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Are You Asking the Question? Strategies for Engaging the Patient in the Diagnosis and Management of Opioid-Induced Constipation

Are You Asking the Question? Strategies for Engaging the Patient in the Diagnosis and Management of Opioid-Induced Constipation

Format

Expert Perspective

Time to Complete

1 hour

Released

March 28, 2017

Expires

March 28, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / Contact Hour (includes 1.00 pharmacology credit)

Accredited Provider


Provided by the Office of Continuing Medical Education, Boston University School of Medicine (BUSM)

Commercial Supporter

This activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP and Takeda Pharmaceuticals International, Inc., U.S. Region.

Program Description

All patients taking a pain medication containing an opioid are at risk for developing adverse effects, specifically opioid-induced constipation (OIC). Therefore all patients being considered for or currently on chronic opioid therapy should be assessed for OIC risk. Because OIC may present with a variety of nonspecific symptoms such as abdominal pain, bloating and decreased bowel movement frequency, clinicians need to be proactive in identifying and managing OIC in all their patients on chronic opioid therapy.

This two-part CME/CNE-certified online publication provides real-world case examples that focus on increasing healthcare clinicians' competence and performance in screening, diagnosing, treating, and managing OIC in partnership with the patient. Participants will learn about: tools to screen patients and talk to them about OIC; criteria and symptoms to better diagnose OIC; and OIC therapeutic options and individualizing patients’ management plans.

Intended Audience

The target audience for this program is primary care clinicians, including physicians, nurse practitioners, physician assistants, and nurses who are treating patients that are taking prescription opioids for chronic pain. Palliative care providers are also welcome to participate in this activity.

Educational Objectives

After completing this activity, the participant will demonstrate the ability to:

  • Integrate individualized preventative measures into current practice for patients initiating opioids, using adaptable office protocols and tools to ensure these recommendations are made
  • Employ skills demonstrated through case-based scenarios and use validated assessment tools to overcome communication barriers in initiating patient-provider conversations about bowel habits, diagnosing opioid induced constipation (OIC), and resolving OIC without compromising pain control

Disclosure of Conflicts of Interest

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve any apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

Faculty

H. Christian Weber, MD
Co-Course Director
Associate Chief and Clinical Director
Gastroenterology and Hepatology
VA Boston Healthcare System
Assistant Professor of Medicine
Assistant Professor of Pathology and Laboratory Medicine
Boston University School of Medicine
Boston, MA

Dr. Weber has disclosed that he serves as a consultant for Allergan and Karos Pharmaceuticals. His spouse serves as a consultant for Neovil Pharmaceuticals AG. He does not plan on discussing unlabeled/investigational uses of a commercial product.

Jason M. Worcester, MD
Co-Course Director
Medical Director
Adult Primary Care
Assistant Professor of Medicine
Boston University School of Medicine
Boston, MA

Dr. Worcester has no relevant financial relationships with any commercial interest and does not plan on discussing unlabeled/investigational uses of a commercial product.

Patricia M. Bruckenthal, PhD, APRN-BC, ANP, FAAN
Associate Dean for Nursing Research and Innovation
Associate Professor
Stony Brook University School of Nursing
Stony Brook, NY

Dr. Bruckenthal has disclosed that she serves as a consultant for Endo Pharmaceuticals, and as a speaker for AstraZeneca and Pernix Therapeutics. She does not plan on discussing unlabeled/investigational uses of a commercial product.

Accredited Provider Disclosure

Kristen Stakelin, MD: CME Course Reviewer for Boston University School of Medicine’s Office of Continuing Medical Education, has indicated no real or apparent conflicts.
Siobhan Nevin, RN, BSN, CWOCN: CNE Course Advisor for Boston University School of Medicine’s Office of Continuing Medical Education, has indicated no real or apparent conflicts.
Patti-Ann Collins, DNP, MSN/MBA, RN: Lead Nurse Planner for Boston University School of Medicine’s Office of Continuing Medical Education, has no relevant financial relationships with any commercial interest.
Christopher Drury, MA, MA: Medical Writer for Boston University School of Medicine’s Office of Continuing Medical Education, has indicated no real or apparent conflicts.
Dana Frazier, CHCP: Program and Grant Manager for Boston University School of Medicine’s Office of Continuing Medical Education, has indicated no real or apparent conflicts.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Boston University School of Medicine designates this enduring educational activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

CNE Contact Hours: 1.00 all of which are eligible for pharmacology credit. Nurses will receive contact hours after completion of an evaluation and claim for credit form.

Disclosure of Unlabeled Use

Faculty members will not discuss any unlabeled/investigational uses of a commercial product.

Fee Information

There is no fee for this educational activity.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Instructions

By reviewing the course content and successfully completing the post-test and evaluation, physicians are entitled to receive 1.00 AMA PRA Category 1 CreditTM and nurses are entitled to receive 1.00 CNE contact hour, all of which is pharmacology credit worthy. A statement of credit will be available to print from your CME History on myCME. Users must:

  • Read the learning objectives and faculty disclosures.
  • Participate in the activity.
  • Successfully complete the post-test, activity evaluation, and claim credit. A post-test score of 75% or higher is required, and you may retake the post-test up to 2 times to achieve a passing score.
  • Your certificate will be available to print from your CME History, located under My Account.

For questions about CME, please contact cme@bu.edu or go to http://bucme.org/.
Add to Queue